Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,416
Closed -$224K 87
2023
Q1
$224K Buy
+1,416
New +$212K 0.04% 90
2022
Q4
Sell
-2,016
Closed -$259K 97
2022
Q3
$259K Sell
2,016
-7,999
-80% -$1.15M 0.06% 74
2022
Q2
$1.41M Buy
10,015
+7,999
+397% +$1.14M 0.4% 25
2022
Q1
$280K Sell
2,016
-100
-5% -$15.3K 0.05% 77
2021
Q4
$369K Hold
2,116
0.05% 87
2021
Q3
$350K Hold
2,116
0.06% 87
2021
Q2
$381K Hold
2,116
0.06% 79
2021
Q1
$408K Sell
2,116
-12,750
-86% -$2.45M 0.07% 80
2020
Q4
$3M Sell
14,866
-44,850
-75% -$9.28M 0.49% 46
2020
Q3
$12.6M Buy
59,716
+57,850
+3,100% +$12.9M 2.28% 18
2020
Q2
$323K Hold
1,866
0.09% 59
2020
Q1
$323K Buy
1,866
+150
+9% +$24.8K 0.09% 59
2019
Q4
$263K Buy
+1,716
New +$256K 0.05% 78

Other funds holding CLX

De Burlo Group's CLX Position: Q2 2023 in Review

De Burlo Group sold out of Clorox (CLX) in Q2 2023, closing a stake of 1,416 shares — an estimated $224K sold.

De Burlo Group first reported a position in CLX in Q4 2019 and held it in 13 quarters. The position peaked at $12.6M in Q3 2020. 1,143 funds tracked by Wall St. Rank hold CLX as of Q2 2023.

  • De Burlo Group reported no remaining Clorox position as of Q2 2023 after selling out during the quarter.
  • De Burlo Group sold 1,416 Clorox shares in Q2 2023, an estimated $224K.
  • De Burlo Group first reported a position in Clorox in Q4 2019 and held it in 13 quarters.
  • De Burlo Group's Clorox position peaked at $12.6M in Q3 2020.
  • 1,143 funds tracked by Wall St. Rank held Clorox as of Q2 2023.

Based on De Burlo Group's 13F filing for Q2 2023, filed 14 Aug 2023.